Comparison of Two Miniscrew Bone-borne Expanders (2 vs 4 Screws) Versus Conventional Hyrax Expander in Adolescents
Prospective Randomized Controlled Study Comparing Dentoalveolar, Skeletal, Periodontal and Nasal/Airway Effects of a Two-miniscrew Bone-borne Expander, a Four-miniscrew Bone-borne Expander, and a Conventional Tooth-borne Hyrax Expander in Adolescents.
1 other identifier
interventional
36
1 country
1
Brief Summary
Rapid maxillary expansion (RME) is used to correct transverse deficiencies of the maxilla. This randomized controlled trial compares three RME devices in adolescents (age 10-15) with at least 8 mm maxillary transverse deficiency: (1) bone-borne expander supported by two palatal miniscrews, (2) bone-borne expander supported by four palatal miniscrews, and (3) conventional tooth-borne Hyrax expander. Devices were placed using static computer-guided miniscrew insertion (where applicable). All participants received the same activation protocol to reach 8 mm expansion. Cone-beam CT scans were obtained pre-treatment (T0) and at 6 months post-treatment (T1). The trial assesses skeletal, dentoalveolar, periodontal, and nasal/airway outcomes. Enrollment: 36 subjects. Study sites: Sapienza University of Rome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedFirst Submitted
Initial submission to the registry
February 4, 2026
CompletedFirst Posted
Study publicly available on registry
February 11, 2026
CompletedFebruary 11, 2026
February 1, 2026
2.8 years
February 4, 2026
February 4, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in maxillary basal width (MaxBas) from baseline (T0) to 6 months post-treatment (T1)
Measurement method: CBCT (Simplant software) distance between alveolar/basal points (points 5-6 as per Podesser/Garib protocol).
at 6 months
Study Arms (3)
Arm 1 (Group A) - Two-miniscrew bone-borne expander
EXPERIMENTALone-borne rapid maxillary expander anchored on two palatal miniscrews inserted in paramedian palatal vault (near first-second premolar area). Miniscrews: self-tapping titanium (Benefit system; PSM Medical Solutions). Placement planned via CBCT-guided CAD/CAM surgical guide (Easy Driver). Activation protocol: Hyrax click 10 mm screw: 4 quarter-turns at placement then 3 quarter-turns/day for 12 days (0.20 mm/turn) until \~8 mm expansion.
Arm 2 (Group B) - Four-miniscrew bone-borne expander
EXPERIMENTALBone-borne rapid maxillary expander anchored on four palatal miniscrews (two paramedian + two parapalatine). Same guided insertion workflow and activation protocol as Group A.
Arm 3 (Group C) - Conventional tooth-borne Hyrax expander
ACTIVE COMPARATORTooth-borne Hyrax expander banded on upper first permanent molars (conventional Hyrax). Same activation protocol as Groups A/B.
Interventions
Hyrax-type tooth-borne expander with bands cemented on upper first molars (Hyrax click 10 mm).
Two palatal miniscrews with custom bone-borne expansion framework (device transmits forces to palatal bone; no tooth bands).
Four palatal miniscrews with custom bone-borne expansion appliances.
Eligibility Criteria
You may qualify if:
- Age 10 to 15 years (under 16 at enrollment).
- Late mixed or permanent dentition.
- Maxillary transverse deficiency ≥ 8 mm (unilateral or bilateral).
- Parent/guardian able to provide written informed consent; participant assent where applicable.
You may not qualify if:
- Poor oral hygiene.
- Prior orthodontic treatment.
- Craniofacial syndromes.
- Cleft lip and/or palate.
- Genetic or congenital diseases likely to affect craniofacial growth or bone quality.
- Inability/unwillingness to attend scheduled follow-up visits.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sapienza University of Rome
Rome, Rm, 00161, Italy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, DDS, PhD
Study Record Dates
First Submitted
February 4, 2026
First Posted
February 11, 2026
Study Start
November 1, 2021
Primary Completion
September 1, 2024
Study Completion
September 1, 2024
Last Updated
February 11, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share